Childhood Acute Megakaryocytic Leukemia (M7) Terminated Phase 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0028563 (Childhood Acute Megakaryocytic Leukemia (M7))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00096148Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaTreatment